|Bid||100.20 x 800|
|Ask||104.20 x 1300|
|Day's Range||100.53 - 102.20|
|52 Week Range||72.06 - 106.45|
|Beta (5Y Monthly)||0.60|
|PE Ratio (TTM)||13.56|
|Earnings Date||Nov. 05, 2020 - Nov. 09, 2020|
|Forward Dividend & Yield||1.68 (1.65%)|
|Ex-Dividend Date||Aug. 14, 2020|
|1y Target Est||106.56|
How far off is AmerisourceBergen Corporation (NYSE:ABC) from its intrinsic value? Using the most recent financial...
Steve Collis, AmerisourceBergen CEO, joins Yahoo Finance’s The First Trade with Alexis Christoforous and Brian Sozzi to discuss the company’s third-quarter earnings report, future outlook for the pharmaceutical industry overall including a COVID-19 vaccine and much more.
Good morning, and thank you all for joining us to the conference call to discuss AmerisourceBergen's Fiscal 2020 Third Quarter Results. On today's call, we will be discussing non-GAAP financial measures.